AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2025
Feb 4, 2025
29745_dirs_2025-02-04_f419d61b-6943-4907-9111-dd0056a4000b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-02-01
Reporting Person: Yuffa Ilya (EVP & President, LLY Int'l)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-01 | Common Stock | M | 3269 | — | Acquired | 23071 | Direct |
| 2025-02-01 | Common Stock | F | 1434.377 | $811.08 | Disposed | 21636.623 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-01 | Restricted Stock Unit | $ | M | 3269 | Disposed | 2025-02-01 | Common Stock (3269) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Capital/Financing Update
2026
May 20
Report Publication Announcement
2026
May 11
Capital/Financing Update
2026
May 8
Declaration of Voting Results & Voting Rights Announcements
2026
May 7
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 29